Device Trial Radar · NCT00638235
Pelvic Floor Repair Systems for Prolapse Repair
Last checked: Nov 19, 2026Latest source record: Oct 28, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
725
Actual
Start
May 2006
Primary completion
Feb 2011
Study completion Sep 2012
Sponsor
- Lead sponsor
- ASTORA Women's HealthNot on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 19, 2008
Design
- Study type
- Observational
- Who can join
- Female only, from 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
1. This is a prospective, multi-center, post market study, which will be conducted under a common protocol. 2. The primary objective of the study is to evaluate long-term efficacy of the AMS Pelvic Floor Repair System devices for prolapse repair. 3. The study population is female subjects \> 21 years of age who require surgical reconstruction of their pelvic floor due to prolapse. 4. The clinical data will be analyzed by comparing post-treatment data with the baseline data, with the subject acting as her own control. The follow-up is for two years after the procedure. 5. Prolapse improvement measured by ICS POP-Q Stage at 12-months will be the primary endpoint of the study. The secondary endpoints include quality of life changes from baseline and adverse event rates.
Conditions
- Pelvic Organ Prolapse
Interventions
AMS Apogee™ with InteProDevice
Mesh implant for posterior wall pelvic organ prolapse
AMS Apogee™ with Intexen LPDevice
Graft implant for posterior wall pelvic organ prolapse
AMS Perigee™ with InteProDevice
Mesh implant for anterior wall pelvic organ prolapse
AMS Perigee™ with IntePro LiteDevice
Mesh implant for anterior wall pelvic organ prolapse
AMS Apogee™ with IntePro LiteDevice
Mesh implant for posterior wall pelvic organ prolapse
AMS Elevate™ Apical & Posteiror with IntePro LiteDevice
Mesh implant for apical and posterior wall pelvic organ prolapse
AMS Elevate™ Apical & Posteiror with IntXen LPDevice
Graft implant for apical and posterior wall pelvic organ prolapse
AMS Elevate™ Anterior & Apical with IntePro Lite (Gen 1, For Study Use Only)Device
Mesh implant for anteiror and apical wall pelvic organ prolapse
AMS Elevate™ Anterior & Apical with IntePro Lite (Gen 2)Device
Mesh implant for anteiror and apical wall pelvic organ prolapse
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent of Subjects With an ICS (International Incontinence Society) POP-Q (Pelvic Organ Prolapse Quantification System) Stage of </= Stage I in the Posterior Compartment at One Year Post ProcedureTime frame: 12-months
- Percent of Subjects With an ICS POP-Q Stage of </= Stage I in the Apical Compartment at One Year Post ProcedureTime frame: 12-months
- Percent of Subjects With an ICS POP-Q Stage of </= Stage I in the Anterior Compartment at One Year Post ProcedureTime frame: 12-months
Locations
28 sites in 7 countries. Site status is shown where the registry gives one.
Kaiser Permanente - Dept. of Obstetrics & Gynecology
Downey, California
Institute for Women's Health & Body
Wellington, Florida
Atlanta Medical Research Institute
Alpharetta, Georgia
25 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.